Abstract
Objective Computational models provide information about cognitive components underlying behavior. When applied to psychopathology-relevant processes, they offer additional insight to observed differences in behavioral performance. Drift diffusion models have been successfully applied to investigate processing efficiency during binary choice tasks. Using these, we examine the association between psychopathology (irritability and inattention) and processing efficiency under different attentional demands.
Method 187 youth with ADHD, DMDD, both disorders, or no major psychopathology (M age=13.09, SD=2.55; 34% female) completed an Eriksen Flanker task. Of these, 87 provided complete data on dimensional measures of the core symptom of DMDD, irritability, and those of ADHD, inattention and hyperactivity.
Results In a categorical analysis (n=187), we found a ADHD-by-DMDD-by task condition interaction on processing efficiency (b=−1.07, p=.01, 95%CI=[−1.89,−.24]), where increases in processing efficiency for non-conflict conditions were larger in youth without psychopathology relative to patients. Analysis of symptom severity (n=87) across diagnosis was consistent with the above analysis, revealing an interaction between symptom dimensions and task condition on processing efficiency (b=−0.10, p=.018, 95%CI[−.18, −.02]). Inattention, and its combined effect with irritability, predicted the magnitude of difference in processing efficiency between conflict and non-conflict conditions.
Discussion Reduced processing efficiency may represent a shared cognitive endophenotype between ADHD and DMDD. Youth high in irritability or inattention may have difficulty adjusting processing efficiency to changing task demands possibly reflecting impairments in cognitive flexibility.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the Intramural Research Program of the NIMH, National Institutes of Health (NIH; ZIAMH002786), and was conducted under NIH Clinical Study Protocols 00-M-0198 and 02-M-0021 (ClinicalTrials.gov ID: NCT00006177 and NCT00025935). JS was supported by a grant from the National Institutes of Health, National Institute of Mental Health, K23MH113731 and the Pediatric Mental Health Institute at Children’s Hospital Colorado and the Division of Child and Adolescent Psychiatry, Department of Psychiatry, University of Colorado School of Medicine. The funding source was not involved in study design; the collection, analysis and interpretation of data; writing of the report; and the decision to submit the article for publication.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data will be made available in compliance with NIH/NIMH guidelines.
